ND Life Sciences

ND Life Sciences is a UK-based biotechnology company specializing in the early detection and monitoring of neurodegenerative disorders, such as Alzheimer's and Parkinson's disease. The company utilizes a proprietary platform to identify specific autoantibody signatures in blood samples that serve as early indicators of disease pathology. By focusing on minimally invasive blood-based biomarkers, ND Life Sciences aims to provide a cost-effective and accessible alternative to traditional PET imaging and cerebrospinal fluid analysis. Their technology is designed to facilitate earlier intervention and support the clinical development of targeted therapeutics by providing better patient stratification. The company's research foundation is closely linked to the Human Genetics group at the University of Nottingham.